487 / 1084
Summary
The regimen of choice depends on patient-, disease- and treatment-
related factors:
• Chemoradiotherapy could be considered for patients in good condition,
with a relatively good prognosis and oligometastatic disease
• Chemotherapy could be considered for patients in relatively good
condition, with a life expectancy >6 months and metastatic disease
• EBRT is recommended for patients with a life expectancy between
three and six months, when there is no need for immediate relief
• Brachytherapy is recommended for patients with a life expectancy
between three and six months, where EBRT would take too long
• In patients with a shorter life expectancy or those with severe
dysphagia/stenosing tumor, endoscopic stent placement is preferred,
which offers instant relief of symptoms